  | Turner, M. C., Radzikowska, U., Ferastraoaru, D. E., Pascal, M., Wesseling, P., McCraw, A., BACKES, C., Bax, H. J., Bergmann, C., Bianchini, R., Cari, L., de Las Vecillas, L., Izquierdo, E., Lind-Holm Mogensen, F., MICHELUCCI, A., NAZAROV, P., NICLOU, S. P., Nocentini, G., OLLERT, M., ... Poli, A. (2024). AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper. Allergy. doi:10.1111/all.15994  Peer Reviewed verified by ORBi |
  | Capelle, C. M., Ciré, S., Hedin, F., HANSEN, M., PAVELKA, L., GRZYB, K., KYRIAKIS, D., Hunewald, O., Konstantinou, M., Revets, D., TSLAF, V., Marques, T. M., GOMES, C., BARON, A., Domingues, O., Gomez, M., Zeng, N., BETSOU, F., MAY, P., ... Hefeng, F. Q. (20 November 2023). Early-to-mid stage idiopathic Parkinson's disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. Nature Communications, 14 (1), 7461. doi:10.1038/s41467-023-43053-0 Peer Reviewed verified by ORBi |
 | Santos da Silva, E., Servais, J.-Y., Kohnen, M., Arendt, V., Staub, T., The Con-Vince Consortium, The CoVaLux Consortium, Krüger, R., FAGHERAZZI, G., WILMES, P., Hübschen, J. M., OLLERT, M., Perez-Bercoff, D., & Seguin-Devaux, C. (06 October 2023). Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern. International Journal of Molecular Sciences, 24 (19), 14965. doi:10.3390/ijms241914965 Peer Reviewed verified by ORBi |
 | de Nies, L., Galata, V., Martin-Gallausiaux, C., Despotovic, M., Busi, S. B., Snoeck, C. J., Delacour, L., Budagavi, D. P., Laczny, C. C., Habier, J., Lupu, P.-C., Halder, R., Fritz, J. V., Marques, T., Sandt, E., O'Sullivan, M. P., Ghosh, S., Satagopam, V., Consortium, C.-V., ... Wilmes, P. (09 March 2023). Altered infective competence of the human gut microbiome in COVID-19. Microbiome, 11 (1), 46. doi:10.1186/s40168-023-01472-7 Peer Reviewed verified by ORBi |
 | Poli, A., Oudin, A., Muller, A., Salvato, I., Scafidi, A., Hunewald, O., Domingues, O., NAZAROV, P., Puard, V., Baus, V., AZUAJE, F., DITTMAR, G., ZIMMER, J., MICHEL, T., MICHELUCCI, A., NICLOU, S. P., & OLLERT, M. (March 2023). Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice. Allergy, 78 (3), 682-696. doi:10.1111/all.15545 Peer Reviewed verified by ORBi |
 | Fischer, A., Badier, N., Zhang, L., Elbéji, A., WILMES, P., Oustric, P., Benoy, C., OLLERT, M., & FAGHERAZZI, G. (30 November 2022). Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. International Journal of Environmental Research and Public Health, 19 (23), 16018. doi:10.3390/ijerph192316018 Peer Reviewed verified by ORBi |
 | Meyrath, M., Szpakowska, M., Plesseria, J.-M., Domingues, O., Langlet, J., Weber, B., Krüger, R., Ollert, M., & Chevigné, A. (09 September 2022). Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in Enzymology, 675, 351-381. doi:10.1016/bs.mie.2022.07.015 Peer Reviewed verified by ORBi |
 | Fischer, A., Zhang, L., Elbéji, A., WILMES, P., Oustric, P., Staub, T., Nazarov, P. V., OLLERT, M., & FAGHERAZZI, G. (August 2022). Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infectious Diseases, 9 (8), 397. doi:10.1093/ofid/ofac397 Peer Reviewed verified by ORBi |
 | Capelle, C., Cire, S., Hansen, M., Pavelka, L., Hedin, F., Konstantinou, M., Revets, D., Tslaf, V., Marques, T., Baron, A., Domingues, O., Zeng, N., May, P., Cosma, A., Balling, R., Krüger, R., Ollert, M., & He, F. (2022). Early-to-mid idiopathic Parkinson’s disease shows a more cytotoxic but declined CD8-regulatory peripheral immune profile. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/51989. doi:10.21203/rs.3.rs-1834770/v1 |
 | Danileviciute, E., Zeng, N., Capelle, C. M., Paczia, N., Gillespie, M. A., Kurniawan, H., Benzarti, M., Merz, M. P., Coowar, D., Fritah, S., Vogt Weisenhorn, D. M., Gomez Giro, G., Grusdat, M., Baron, A., Guerin, C., Franchina, D. G., Léonard, C., Domingues, O., Delhalle, S., ... He, F. (26 May 2022). PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains T(reg) homeostasis during ageing. Nature Metabolism, 4 (5), 589-607. doi:10.1038/s42255-022-00576-y Peer Reviewed verified by ORBi |
 | Capelle, C. M., Ciré, S., Domingues, O., Ernens, I., Hedin, F., Fischer, A., Snoeck, C. J., Ammerlaan, W., Konstantinou, M., Grzyb, K., Skupin, A., Carty, C. L., Hilger, C., Gilson, G., Celebic, A., Wilmes, P., Del Sol, A., Kaplan, I. M., Betsou, F., ... He, F. (2022). Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients. Cell Reports Medicine, 3 (4), 100600. doi:10.1016/j.xcrm.2022.100600 Peer reviewed |
 | Capelle, C. M., Chen, A., Zeng, N., Baron, A., Grzyb, K., Arns, T., Skupin, A., Ollert, M., & He, F. (2022). Stress hormone signalling inhibits Th1 polarization in a CD4 T-cell-intrinsic manner via mTORC1 and the circadian gene PER1. Immunology, 165 (4), 428--444. doi:10.1111/imm.13448 Peer Reviewed verified by ORBi |
 | Zeng, N.* , Capelle, C. M.* , Baron, A., Kobayashi, T., Cire, S., Tslaf, V., Leonard, C., Coowar, D., Koseki, H., Westendorf, A. M., Buer, J., Brenner, D., Krüger, R., Balling, R., Ollert, M., & He, F. (2022). DJ‐1 depletion prevents immunoaging in T‐cell compartments. EMBO Reports, 23 (3). doi:10.15252/embr.202153302 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Zeng, N., Capelle, C., Baron, A., Cire, S., Leonard, C., Coowar, D., Koseki, H., Westendorf, A., Buer, J., Brenner, D., Krüger, R., Balling, R., Ollert, M., & He, F. (2021). DJ-1 depletion slows down immunoaging in T-cell compartments. bioRxiv. doi:10.1101/2021.05.21.445139 |
 | Holuka, C., Snoeck, C. J., Mériaux, S. B., Ollert, M., Krüger, R., Turner, J., & The Con-Vince Consortium. (2021). Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity. Journal of Clinical Medicine, 10 (10). doi:10.3390/jcm10102159 Peer Reviewed verified by ORBi |
 | Wilmes, P., Zimmer, J., Schulz, J., Glod, F., Veiber, L., Mombaerts, L., Rodrigues, B., Aalto, A., Pastore, J., Snoeck, C. J., Ollert, M., Fagherazzi, G., Mossong, J., Goncalves, J., Skupin, A., & Nehrbass, U. (2021). SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. The Lancet Regional Health. Europe, 4, 100056. doi:10.1016/j.lanepe.2021.100056 Peer Reviewed verified by ORBi |
 | CZOLK, R. M., Klueber, J., Sørensen, M., WILMES, P., Codreanu-Morel, F., Skov, P. S., HILGER, C., Bindslev-Jensen, C., OLLERT, M., & KUEHN, A. (2020). IgE-Mediated Peanut Allergy: Current and Novel Predictive Biomarkers for Clinical Phenotypes Using Multi-Omics Approaches. Frontiers in Immunology, 11, 594350. doi:10.3389/fimmu.2020.594350 Peer Reviewed verified by ORBi |
 | Wierz, M., Pierson, S., Guyonnet, L., VIRY, E., Lequeux, A., Oudin, A., NICLOU, S. P., OLLERT, M., BERCHEM, G. J. M. J., JANJI, B., Guérin, C., PAGGETTI, J., & MOUSSAY, E. (05 April 2018). Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia. Blood, 131 (14), 1617-1621. doi:10.1182/blood-2017-06-792267 Peer Reviewed verified by ORBi |